Progress toward a Respiratory Syncytial Virus Vaccine | Zendy

Kathleen M. Neuzil | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Progress toward a Respiratory Syncytial Virus Vaccine

Author(s) -

Kathleen M. Neuzil

Publication year - 2016

Publication title -

clinical and vaccine immunology

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.649

H-Index - 77

eISSN - 1556-6811

pISSN - 1556-679X

DOI - 10.1128/cvi.00037-16

Subject(s) - virology , virus , medicine , immunology , respiratory system , pneumovirinae , immune system , paramyxoviridae , viral disease

In accompanying papers (P. L. Acosta, M. T. Caballero, and F. P. Polack, Clin Vaccine Immunol 23:189-195, 2016, http://dx.doi.org/10.1128/CVI.00609-15; M. Vissers, I. M. L. Ahout, M. I. de Jonge, and G. Ferwerda, Clin Vaccine Immunol 23:243-245, 2016, http://dx.doi.org/10.1128/CVI.00590-15) in this issue of Clinical and Vaccine Immunology, the history of and immune mechanisms underlying vaccine-enhanced respiratory syncytial virus (RSV) disease and of investigations of mucosal antibodies and their association with viral load in RSV-infected children, respectively, are described. This commentary discusses RSV vaccine candidates, target populations, and the challenges associated with achieving a safe and effective vaccine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research